DexCom (DXCM) Tops Q4 EPS by 37c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $68.86 --0%
EPS Growth %: +27.1%
Financial Fact:
Development grant and other revenue: 0
Today's EPS Names:
PKE, LNN, More
EPS Growth %: +27.1%
Financial Fact:
Development grant and other revenue: 0
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.54, $0.37 better than the analyst estimate of $0.17. Revenue for the quarter came in at $338 million versus the consensus estimate of $307.52 million.
GUIDANCE:
DexCom sees FY2019 revenue of $1.175-1.225 billion, versus the consensus of $1.28 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- BofA on Meta Platforms Inc. (META): 'AI capacity is valuable, maintain Buy'
- Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
